The consensus estimate for Q3 2025 revenue is $204.90 million, and the earnings are expected to come in at -$0.22 per share.

Fibromyalgia, which causes chronic pain all over the body, is poorly understood, but two studies – made up of millions of ...

Alastair Reeves has followed in his father's footsteps, using genetics to help farmers solve problems on farm by breeding ...

The field of genetics has evolved rapidly in recent years, however early understanding of inheritance patterns began much ...

Analysts estimate that Myriad Genetics will report an earnings per share (EPS) of $-0.05. The announcement from Myriad Genetics is eagerly anticipated, with investors seeking news of surpassing ...

Genetic testing company Myriad Genetics (NASDAQ:MYGN) will be reporting results this Monday after the bell. Here’s what to ...

A large biobanking effort captures genetic and health data from half a million people in Taiwan, widening the diversity of ...

Fintel reports that on October 29, 2025, Wedbush initiated coverage of Opus Genetics (NasdaqCM:IRD) with a Outperform ...

The obesity rate has been steadily climbing and so have scientific efforts to understand why. A new study, published in ...

BYU plant and wildlife professors Rick Jellen and Jeff Maughan, together with an international consortium of researchers, ...

Women are significantly more likely than men to develop Alzheimer's disease. Earlier age at menopause is associated with a ...

Jennifer Lopez's longevity is a testament to consistency, not luck. To adopt the J-Lo blueprint, you must embrace the ...